As more health technology assessment (HTA) bodies seek to implement patient involvement, there is a desire learn from other HTA about their experiences and understand what approaches can be used which ones make real difference HTA. This difficult, as the impact of involvement in not well documented. study aims promote further discussion ways HTAs by studying stories impact.In multi-stakeholder workshop, experts leading four shared examples where they believed made difference, then reflected...

Abstract Objective Accounts of patient experiences are increasingly used in health technology assessment (HTA) processes. However, we know little about their impact on the decision-making process. This study aims to assess level and type input highly specialised technologies (HSTs) interventional procedures (IPs) guidance at National Institute for Health Care Excellence (NICE). Methods A questionnaire was developed capture quantitative qualitative data amount into NICE HTAs. It completed by...

To develop an international template to support patient submissions in Health Technology Assessments (HTAs). This was be based on the experience and feedback from implementation use of Scottish Medicines Consortium's (SMC) Summary Information for Patient Groups (SIP).To gather SMC experience, web-based surveys were conducted with pharmaceutical companies groups familiar SIP. Semistructured interviews representatives HTA bodies undertaken, along group discussions those less SIP, explore...

Abstract The National Institute for Health and Care Excellence (NICE) worked with patients staff from six patient organizations to review existing health technology assessment (HTA) methods coproduce proposals improve the following: involvement, how evidence is identified considered by committees, support offered stakeholders. This engagement important factors that HTA bodies need understand enable meaningful public involvement (PPI), such as having clearly documented processes, appropriate...

Introduction The National Institute for Health and Care Excellence (NICE) heard from small organizations how resource intensive difficult it is them participate in medicines health technology assessments (HTA) since the COVID-19 pandemic. To provide additional support these or to alternative patient input, NICE explored implementing surveys directly with patients share stakeholder NICE’s HTA committees. Methods Patient colleagues at were included background investigation. Informal interviews...

Introduction Involving patients in the health technology assessment (HTA) lifecycle is a core principle at National Institute for Health and Care Excellence (NICE). To achieve this, NICE has adopted mixed approach to patient public involvement engagement (PPIE) spanning entire appraisal process. ensure PPIE enables meaningful involvement, engaged with stakeholders review its effectiveness identify areas improvement. Methods In 2023, an independent consultant reviewed NICE’s staff external...

INTRODUCTION: Written patient evidence is submitted to the National Institute for Health and Care Excellence (NICE) by organizations their nominated experts. We reviewed impact that had on committee's decision making. This local learning can help generate global opportunities Technology Assessment (HTA) bodies groups further develop understanding methodology about how support HTA making ultra-orphan conditions. METHODS: There were two phases. Phase one was an online questionnaire of...

Introduction Written evidence is submitted to the National Institute for Heath and Care Excellence (NICE) by patient organisations all ultra-orphan evaluations. To enhance capability of involvement at NICE further develop understanding how generated input in conditions can support Health Technology Assessment (HTA) agencies beyond 2020, Public Involvement Programme systematically reviews impact has on committee decision making. Methods This study captured data from September 2017 August 2018...

Introduction Patient involvement is a core principle of the National Institute for Health and Care Excellence (NICE) we continually strive to improve patient in health technology assessments (HTAs) medicines. We iteratively surveyed reviewed how can be improved with organizations, experts, NICE HTA decision-making committees, staff. re-examined feedback that collect on an ongoing basis, as well one-off evaluations, check involvement. Improvements ranged from support work stakeholders...

INTRODUCTION: The National Institute for Health and Care Excellence (NICE) medicines health technology assessments (HTAs) involve patients throughout (1): scoping the topic, evidence submission, attending committee as ‘patient experts’, consultation appeal. A 2013 Select Committee report stated “It is important credibility of NICE decisions that it makes patient voice effectively openly represented in all its work” (2). We thus wished to build on previous evaluation projects with more formal...

INTRODUCTION: Patient evidence is submitted to the National Institute for Health and Care Excellence (NICE) by patient organizations individual experts. Previously NICE developed a new organization submissions template, based on international HTAi submission template medicines (1). The was reviewed surveying committee members also who had used template. findings were presented at 2016. limitation of that review low response rate from organizations. key recommendation extend survey include...

INTRODUCTION: The National Institute for Health and Care Excellence (NICE) has a formal policy stating patients, carers citizens are involved throughout each Technology Assessment (HTA). One key way patient/carer organizations is by nominating patient experts to participate in appraisal committee meetings. A NICE 2014 report (1) on Patient Experts experiences identified need routinely survey Experts. This been ongoing since October 2015. study highlights findings, including new...

Introduction: The National Institute of Health and Care Excellence (NICE) assesses the efficacy safety interventional procedures for use in Service (NHS). Since 2006, NICE's Public Involvement Programme (PIP) has obtained ‘patient commentary’ to inform committee decisions, using a questionnaire asking patients about their experience procedure including benefits, disadvantages side effects. Commentary is considered by alongside other evidence. PIP piloted project to: capture impact patient...

Introduction: The National Institute for Health and Care Excellence (NICE) strategic review of its public involvement offer included a survey with stakeholders to explore how NICE can continue deliver high quality, meaningful in rapidly-changing environment. Methods: staff, committee lay members, an external academic ran the project designed online survey. was open two weeks. A purposive sample, recruited through various communication channels, invited participate. sample comprised: (i)...

Introduction Involving patients and the public in health technology assessment (HTA) has always been fundamental to NICE. To ensure appropriate method of patient involvement remains relevant evolving types HTA, NICE uses varying methods involvement. These have reviewed they remain current for HTA now beyond 2020, also give guidance on approaches that should form a standard baseline those could be optional. Methods We identified mapped different used at across five HTAs: diagnostics; medical...

Introduction Involving patients is a core principle which governs the work of National Institute for Health and Care Excellence (NICE). To improve how patient evidence identified considered in health technology assessments (HTAs), NICE worked with organizations to review existing HTA methods co-designed proposals change. Methods A working group, including six organizations, oversaw project, identifying co-designing options improvement. We held stakeholder event twenty-two identify themes...

Introduction Involving patients and community organizations in the health technology assessment (HTA) lifecycle is a core principle at National Institute for Health Care Excellence (NICE) helps build public confidence healthcare decision-making. From 2019 to2021 NICE assessed HIV-1 medicine first time. This presented new opportunities challenges engaging with Human Immunodeficiency Virus (HIV) who hadn’t participated HTA before. To understand their experience, we collected feedback on impact...

Introduction Involving patients in the health technology assessment (HTA) lifecycle is a core principle at National Institute for Health and Care Excellence (NICE) that helps build public confidence healthcare decision-making. The last stage this an appeal whereby stakeholders, including patient organizations, can against HTA committee’s decision based on two specific grounds: (i) committee has failed to act fairly or NICE exceeded its powers; (ii) recommendation unreasonable considering...

Introduction Involving patients in the health technology assessment (HTA) lifecycle is a core principle at National Institute for Health and Care Excellence (NICE). We include both patient organizations experts, which helps build public confidence healthcare decision-making. continually work with experts to improve their experience ability participate by seeking expert feedback after every committee meeting. Methods sent an anonymous survey containing five-point Likert scale open text boxes...